Cancer Innovation
Country
United States
Northern America
Subject Area and Category
Biochemistry, Genetics and Molecular Biology
└
Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Q1
└
Drug Discovery
Q2
└
Oncology
Q2
Publisher
SJR 2025
0.921
Q1
SJR Score
H-Index
13
Citations / Doc (2yr)
3.78
Total Docs. (latest)
55
Total Citations (3yr)
443
Publication type
Journals
ISSN
27709191, 27709183
Coverage
2022-2026
Journal Rank
#5,573
Subject Categories
Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Q1
Drug Discovery
Q2
Oncology
Q2
Pharmacology (medical)
Q2
Cancer Research
Q3
Subject Areas
Detailed Metrics
| Total Docs. (latest) | 55 |
| Total Docs. (3 years) | 124 |
| Total Refs. | 3,365 |
| Total Citations (3 years) | 443 |
| Citable Docs. (3 years) | 115 |
| Citations / Doc. (2 years) | 3.78 |
| Ref. / Doc. | 61.18 |
| % Female | 45.5% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Frequently Asked Questions
What is the impact factor of Cancer Innovation?
The official Journal Impact Factor (JIF) is published by Clarivate in the Journal Citation Reports (JCR) and is not listed on this page. Based on SCImago data, Cancer Innovation has an SJR of 0.921 and is ranked Q1.
What is the SJR and quartile of Cancer Innovation?
Cancer Innovation has an SJR (SCImago Journal Rank) of 0.921 and its best quartile is Q1.
What is the H-index of Cancer Innovation?
The H-index of Cancer Innovation is 13, meaning 13 of its articles have each been cited at least 13 times.
Is Cancer Innovation indexed in Scopus?
Yes. Cancer Innovation is active in Scopus (Scopus Source List, August 2026).
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.